The association of a nucleobindin 2 gene (NUCB2) variant with childhood adiposity

Gene

Volumn 516, Issue 1, 2013, Pages 48-52

  Chen, Yan Yan ^a   Chan, Raymond Ming En ^b   Tan, Karen Mei Ling ^b   Poh, Larry Kok Seng ^b   Loke, Kah Yin ^b   Wang, Jin Ping ^c   Li, Hui ^c   Hu, Ying Hua ^c   Wang, Lin ^d   Lee, Kok Onn ^e   Li, Guang Wei ^d   Lee, Yung Seng ^b  

^a FUWAI HOSPITAL   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Da Qing First Hospital   (China)

^d CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^e Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

Adiposity; Children; NUCB2

Indexed keywords

NEUROPEPTIDE; NUCLEOBINDIN 2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BODY MASS; CHILD; CHILDHOOD OBESITY; CHINA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGH BIRTH WEIGHT; HUMAN; LOW BIRTH WEIGHT; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN;

ADIPOSITY; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CALCIUM-BINDING PROTEINS; CHILD; CHILD, PRESCHOOL; CHINA; DNA PRIMERS; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINEAR MODELS; NERVE TISSUE PROTEINS; OBESITY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SINGAPORE;

EID: 84873086131     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.12.017     Document Type: Article

References (16)

1. Alemzadeh R., Lifshitz F. Childhood obesity. Pediatric Endocrinology 1996, 753-774. Marcel Dekker, New York. F. Lifshitz (Ed.).
2. Bailey S.D., et al. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population. Diabetes 2006, 55:2896-2902.
3. Chen Y.Y., et al. Longitudinal study of childhood adiposity and the risk of developing components of metabolic syndrome-the Da Qing children cohort study. Pediatr. Res. 2011, 70:307-312.
4. Fort P., et al. The satiety molecule nesfatin-1 is co-expressed with melanin concentrating hormone in tuberal hypothalamic neurons of the rat. Neuroscience 2008, 155:174-181.
5. Garcia-Galiano D., Navarro V.M., Gaytan F., Tena-Sempere M. Expanding roles of NUCB2/nesfatin-1 in neuroendocrine regulation. J. Mol. Endocrinol. 2010, 45:281-290.
6. Lee Y.S., Poh L.K., Kek B.L., Loke K.Y. The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 2007, 56:2622-2630.
7. Lee Y.S., Kek B.L., Poh L.K., Saw S.M., Loke K.Y. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children. J. Pediatr. Gastroenterol. Nutr. 2008, 47:172-178.
8. Mei Z., Grummer-Strawn L.M., Pietrobelli A., Goulding A., Goran M.I., Dietz W.H. Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am. J. Clin. Nutr. 2002, 75:978-985.
9. Oh I.S., et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006, 443:709-712.
10. Ramanjaneya M., et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010, 151:3169-3180.
11. Rogers I. The influence of birthweight and intrauterine environment on adiposity and fat distribution in later life. Int. J. Obes. Relat. Metab. Disord. 2003, 27:755-777.
12. Shimizu H., et al. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 2009, 150:662-671.
13. Stengel A., et al. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology 2009, 150:4911-4919.
14. Tan B.K., Hallschmid M., Kern W., Lehnert H., Randeva H.S. Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment. J. Clin. Endocrinol. Metab. 2011, 96:E669-E673.
15. Tsuchiya T., et al. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin. Endocrinol. (Oxf) 2010, 73:484-490.
16. Zegers D., Beckers S., Mertens I.L., Van Gaal L.F., Van Hul W. Association between polymorphisms of the nesfatin gene, NUCB2, and obesity in men. Mol. Genet. Metab. 2011, 103:282-286.